Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66243-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- CA9 antibody
- Antibody type
- Monoclonal
- Description
- CA9 antibody (Cat. #66243-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, pig, rabbit and has been validated for the following applications: FC, IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Porcine, Rabbit
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1G4G5
- Vial size
- 20ul, 150ul
Submitted references Ketoconazole-carbonic anhydrase inhibitors as potential anticancer agents.
Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC.
Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition.
Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes.
Tumor microenvironment in a minipig model of spinal cord glioma.
ATP6V0D1 promotes alkaliptosis by blocking STAT3-mediated lysosomal pH homeostasis.
PFC@O(2) Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC.
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Andreucci E, Biagioni A, Peri S, Di Menna N, Pinto M, Martinelli S, Papucci L, Magnelli L, Renzi G, Selleri S, Angeli A, Capasso C, Carta F, Supuran CT
European journal of medicinal chemistry 2026 Feb 15;304:118504
European journal of medicinal chemistry 2026 Feb 15;304:118504
Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC.
Lu H, Liu H, Yan R, Ma W, Liu H, Liu R, Sun Y, Ye L, Gao P, Jia W, Zhang P, Zhang H
Cell reports 2024 Dec 24;43(12):114996
Cell reports 2024 Dec 24;43(12):114996
Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition.
Chen F, Lin J, Kang R, Tang D, Liu J
Molecular carcinogenesis 2024 Aug;63(8):1515-1527
Molecular carcinogenesis 2024 Aug;63(8):1515-1527
Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes.
Chen P, Li Z, Liang Y, Wei M, Jiang H, Chen S, Zhao Z
International journal of general medicine 2023;16:2503-2518
International journal of general medicine 2023;16:2503-2518
Tumor microenvironment in a minipig model of spinal cord glioma.
Tora MS, Neill SG, Lakhina Y, Assed H, Zhang M, Nagarajan PP, Federici T, Gutierrez J, Hoang KB, Du Y, Lei K, Boulis NM
Journal of translational medicine 2023 Sep 27;21(1):667
Journal of translational medicine 2023 Sep 27;21(1):667
ATP6V0D1 promotes alkaliptosis by blocking STAT3-mediated lysosomal pH homeostasis.
Chen F, Zhu S, Kang R, Tang D, Liu J
Cell reports 2023 Jan 31;42(1):111911
Cell reports 2023 Jan 31;42(1):111911
PFC@O(2) Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC.
Lan Z, Zou KL, Cui H, Chen H, Zhao YY, Yu GT
Journal of clinical medicine 2023 Jan 10;12(2)
Journal of clinical medicine 2023 Jan 10;12(2)
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Liu Q, Luo Q, Feng J, Zhao Y, Ma B, Cheng H, Zhao T, Lei H, Mu C, Chen L, Meng Y, Zhang J, Long Y, Su J, Chen G, Li Y, Hu G, Liao X, Chen Q, Zhu Y
eLife 2022 Aug 1;11
eLife 2022 Aug 1;11
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Zheng S, Zou Y, Liang JY, Xiao W, Yang A, Meng T, Lu S, Luo Z, Xie X
Molecular oncology 2020 Nov;14(11):2814-2833
Molecular oncology 2020 Nov;14(11):2814-2833
No comments: Submit comment
No validations: Submit validation data